for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

India's Strides Arcolab unit, Pfenex in biosimilars JV

MUMBAI, April 17 (Reuters) - Agila Biotech, a unit of Indian drugmaker Strides Arcolab, and U.S.-based Pfenex Inc will develop and commercialise six biosimilars for global markets through a joint venture, the two companies said in a statement.

Agila Biotech will hold a 51 percent stake in the venture, but both parties will have equal say regarding product development and commercialisation, they said late on Tuesday.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up